RedHill Biopharma (RDHL)
RedHill Biopharma - RedHill Biopharma Advancing Opaganib Options for Novel Dual Host Directed and Direct Acting Antiviral Approach for Ebola Outbreak Biodefense Platforms
RedHill Biopharma - RedHill Biopharma Advancing Opaganib Options for Novel Dual Host Directed and Direct Acting Antiviral Approach for Ebola Outbreak Biodefense Platforms
Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026
McKesson Corporation - McKesson Closes Strategic Investment with Apollo Funds for Minority Interest in Medical-Surgical Solutions
Enveric Biosciences Initiates Investigational New Drug (IND)-enabling Genotoxicity Studies of Lead Neuroplastogen Candidate EB-003
BullFrog AI Announces New Commercial Leadership Team to Execute Growth Strategy for its Integrated Pharma AI Platform
Multidisciplinary Physician Panel to Share Real-World Benefits of bioAffinity Technologies’ Noninvasive CyPath Lung Cancer Test in Upcoming Society for Advanced Bronchoscopy Webinar
Plug Power Strengthens Liquidity Through $44 Million Federal ITC Transfer for St. Gabriel Hydrogen Facility
Synchrony to Participate in the Morgan Stanley US Financials Conference
ProKidney Appoints Kenneth Locke as Chief Technical Officer
NXG Cushing® Midstream Energy Fund (NYSE: SRV) Announces 11.1% Distribution Increase